Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2022-09-06 / Molecules 2022 Sep;27(18)Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
/in Brain Tumors in Children, Dendritic Cells, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2022-08-24 / Pharmaceutics 2022 Aug;14(9)Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2022-08-21 / Cancers (Basel) 2022 Aug;14(16)Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities
/in Dendritic Cells, International Publications /von 2022-08-10 / Immunol Invest 2022 Nov;51(8):2133-2158Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
/in Breast Cancer, Dendritic Cells, International Publications /von 2022-08-03 / J Control Release 2022 Sep;349:844-875Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2022-08-01 / Int Immunopharmacol 2022 Sep;110:109016Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2022-07-25 / Epigenomics 2022 Jul;14(14):865-886Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2022-07-22 / Front Mol Biosci 2022;9:816510An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2022-07-15 / Clin Cancer Res 2022 Jul;28(14):3053-3065
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
- Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
- Immunotherapy in breast cancer: an overview of current strategies and perspectives